Indivior (NASDAQ:INDV) Shares Up 3.9% – Here’s What Happened

Indivior PLC (NASDAQ:INDV) shot up 3.9% on Thursday . The company traded as high as $8.49 and last traded at $8.46. 95,739 shares changed hands during trading, a decline of 78% from the average session volume of 434,269 shares. The stock had previously closed at $8.14.

Analyst Ratings Changes

INDV has been the subject of several research reports. Piper Sandler reissued an “overweight” rating and set a $15.00 price target (down from $22.00) on shares of Indivior in a report on Friday, October 11th. Craig Hallum decreased their price target on shares of Indivior from $20.00 to $16.00 and set a “buy” rating on the stock in a research note on Friday, October 11th.

Indivior Trading Down 0.3 %

The firm has a market capitalization of $1.18 billion, a P/E ratio of 856.00 and a beta of 0.68. The company has a quick ratio of 0.68, a current ratio of 0.85 and a debt-to-equity ratio of 23.50. The firm has a 50 day moving average of $10.50 and a 200-day moving average of $14.26.

Indivior (NASDAQ:INDV) last issued its quarterly earnings results on Thursday, July 25th. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.04. Indivior had a negative return on equity of 654.82% and a negative net margin of 12.29%. The company had revenue of $299.00 million for the quarter, compared to analysts’ expectations of $285.90 million. On average, equities research analysts predict that Indivior PLC will post 1.7 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in shares of Indivior by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 5,899,190 shares of the company’s stock valued at $90,081,000 after purchasing an additional 52,836 shares in the last quarter. Cannon Global Investment Management LLC acquired a new position in Indivior in the 1st quarter worth about $563,000. Forsta AP Fonden acquired a new position in shares of Indivior in the first quarter valued at approximately $641,000. M&G Plc bought a new position in shares of Indivior during the first quarter valued at $2,518,000. Finally, Toronto Dominion Bank lifted its holdings in shares of Indivior by 58.0% during the first quarter. Toronto Dominion Bank now owns 2,094,865 shares of the company’s stock worth $44,872,000 after purchasing an additional 769,000 shares during the period. 60.33% of the stock is owned by institutional investors.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.